Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies - Wikidata - awgldk - TriplyDB

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

http://www.wikidata.org/entity/Q28656460

about

Principles of antibody-mediated TNF receptor activation Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies.Impact of Exogenous Galectin-9 on Human T Cells: CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION.Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses F-fucoidan from Saccharina japonica is a novel inducer of galectin-9 and exhibits anti-allergic activity Blockage of Galectin-receptor Interactions by α-lactose Exacerbates Plasmodium berghei-induced Pulmonary Immunopathology.The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy.Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.Galectin-9: From cell biology to complex disease dynamics.Galectin-9 binds to O-glycans on protein disulfide isomerase.CD14+ monocyte-derived galectin-9 induces natural killer cell cytotoxicity in chronic hepatitis C.Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells.4-1BB ligand signaling to T cells limits T cell activation.Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.Acute Stimulation Generates Tim-3-expressing Th1-type CD4 T Cells That Persist In Vivo and Show Enhanced Effector Function.Role of Galectins in Tumors and in Clinical Immunotherapy.Current perspectives of SA-4-1BBL in immune modulation during cancer.Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis.CD137-CRDI is not necessary in the role of contacting its natural ligand.A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis.Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation.Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral Infections.Not All Immune Checkpoints Are Created Equal Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab

P2860

Q26796270-FA4D4AEA-ACA9-4F4C-AA1D-2DBF9B323F07 Q26996518-33CD74C4-D000-4F43-BE79-56EB5C582028 Q27012963-36F160A0-508C-44A3-8AE0-4F361E4A3EA7 Q33426409-24134924-BCFF-433D-BEE4-46E8D4977207 Q35860538-7996F3BB-F591-47FF-872B-4F10801EF3D7 Q35974260-A04F214C-0874-4D19-8748-5E374CC369E6 Q36940326-6FF90915-3319-4304-B2A6-FD6BF627B33F Q37067033-FFEF7E7D-FA89-48DA-AA49-5D8F54787B71 Q37198958-A3165A3C-DCF9-4D8B-8D5B-DF006ED609F0 Q38373689-8BB28FC0-3003-4CF8-9ABA-22AD1F05C655 Q38698632-5846378F-4D03-47CE-93E5-C1F7733C1BAD Q38844576-4AEB3F28-8CA7-411F-A57E-F1225FBC2268 Q38942909-604FCDA0-3655-4E4E-B6C7-9DBF3E44938D Q40082362-EB75B133-2DC4-4149-823E-5B5BE55E8310 Q40536621-BF091C1E-BD6E-43B2-9EB8-DA022CD2D0C8 Q41636712-741202DB-7C55-4C6D-AF01-798E2FDF1C2F Q43074668-75F815E6-EDFD-4AE8-A2C9-72CCA2491BCB Q44000801-F45DBEF4-3A33-494B-A9F2-0F3D0D7065DC Q47292379-62A46794-8734-47DF-A12C-8535600BD219 Q47556597-C5B3B0E0-D1FB-4CBF-B34B-80B45D705662 Q48124343-1BDB0D92-0FC2-4B26-97FD-44B48D561268 Q49875788-DA171125-00BD-4096-A6C6-CF86962F550C Q50545420-A6B2F11C-5C9E-4E96-8C26-109930E9D9C4 Q50783362-BAC620FA-54BA-4742-9DEE-5C214D33A505 Q51689120-D00832A1-32D6-4BB4-AE9F-2C8AFA4FCEB7 Q52369544-E5C4AC6B-7B62-4E67-B167-03243FEF319A Q55009853-E4D477B0-04FB-4B57-8815-F893B392FEEF Q56889626-DA4F8982-592A-42F6-8497-A6954E6CE4A0 Q58586476-20ED06D5-5CC2-4A25-9712-15A62745EDD7

P2860

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

http://www.wikidata.org/entity/Q28656460

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@ast

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@en

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@nl

type

label

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@ast

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@en

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@nl

prefLabel

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@ast

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@en

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@nl

P1433

Q28656460-FE11E17B-09CB-4628-8EB0-7F0583BE1C9E

P1476

Q28656460-D7428C71-BF20-4194-93B6-9372C22B8ED4

P2093

Q28656460-4330E5D9-40B4-48AC-97C5-1EBC33C6C425

Q28656460-5F134D03-DA02-4618-B107-17E3827C118A

Q28656460-72291D02-E507-4ECE-82E0-852AA041FD60

Q28656460-8E928898-69E8-4FC4-9C80-03E896ECC456

Q28656460-C236B5FB-AEB2-4259-98A7-40F83EAE2A5B

Q28656460-E6C82077-399B-4A96-AE7A-020E62498808

Q28656460-E7917914-84E1-4DF9-A12B-78B7FEAD21D3

P2860

Q28656460-0E13F7F9-775C-4419-9B3F-5C355E4390D2

Q28656460-115CBE03-D0B8-4576-939F-79893056E1E1

Q28656460-140387E9-9F16-4C7E-830D-44A87C4EB279

Q28656460-1C124B2A-166A-48F1-9278-25BAA664084E

Q28656460-1F8A02CB-7250-4FAC-BDE3-80DF3CCC77D9

Q28656460-21DC39CD-8CB3-4303-A145-F64D58A6D5FC

Q28656460-3448AC1D-D13E-472F-953F-B52FB58C3E40

Q28656460-396FD8B5-2E77-42DA-A50E-03EA70718C3F

Q28656460-3F9E1731-9E74-4DC1-9530-7BE5D51F04E0

Q28656460-4A82FB9A-4F5B-4631-89DC-CC97FDDD3588

P304

Q28656460-D24F68AA-8BCF-4673-B8D8-77D158D0DBE5

P31

Q28656460-ECE4C8AE-94AB-4F52-9E1D-85480F83379C

P3181

Q28656460-B4CD5B26-2731-452D-8351-D9288AD082AB

P356

Q28656460-E6095B82-D046-47D8-B029-38B5ADBB454D

P407

Q28656460-02F9A6EC-1E92-404E-9320-561AA3722D80

P433

Q28656460-C455477F-10FB-46AE-805D-C53AADCD8F46

P478

Q28656460-53E3D2C3-CCB7-48DD-9AA1-B0157A1F4E1D

P50

Q28656460-419558AA-921F-4789-B484-E6594564882A

Q28656460-837086BC-FE88-4D57-AE40-C5D4E6227F19

Q28656460-F8406BC0-BCE7-4083-ACF4-F41344AA7DB1

P577

Q28656460-366D3E3A-3B53-438C-9800-A7573187C325

P5875

Q28656460-1205A60F-0A0D-48DE-A779-4E1CC726A51E

P698

Q28656460-730E6E28-6393-48EB-8729-88E1ACBCD625

P921

Q28656460-395AC6EC-AA27-495B-8166-4CF1147A0DB6

P932

Q28656460-26CC4F07-D7FE-411D-97B2-5C45EC949CE3

P3181

P356

P1433

Journal of Experimental Medicine

P1476

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies

@en

P2093

Amit Kumar Mehta

http://www.w3.org/2001/XMLSchema#string

Dirk M Zajonc

http://www.w3.org/2001/XMLSchema#string

Ivana Nemčovičová

http://www.w3.org/2001/XMLSchema#string

Michael Croft

http://www.w3.org/2001/XMLSchema#string

Mitsuomi Hirashima

http://www.w3.org/2001/XMLSchema#string

Seung-Woo Lee

http://www.w3.org/2001/XMLSchema#string

Toshiro Niki

http://www.w3.org/2001/XMLSchema#string

P2860

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry

Galectin-9 functionally impairs natural killer cells in humans and mice

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease

cDNA sequences of two inducible T-cell genes

Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function

The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily

Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1

TNF/TNFR family members in costimulation of T cell responses

Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes

P304

1433-1448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1446641

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.20132687

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

211

http://www.w3.org/2001/XMLSchema#string

P50

Shravan Madireddi

P577

2014-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263355281

http://www.w3.org/2001/XMLSchema#string

P698

24958847

http://www.w3.org/2001/XMLSchema#string

P921

P932

4076583

http://www.w3.org/2001/XMLSchema#string